VERICEL CORPORATION - COMMON STOCK

Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance

29 фев 2024 04:55:00 Источник Nasdaq GlobeNewswire

Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024

27 фев 2024 05:30:00 Источник Nasdaq GlobeNewswire

Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024

15 фев 2024 05:30:00 Источник Nasdaq GlobeNewswire

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

05 фев 2024 05:30:00 Источник Nasdaq GlobeNewswire

Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results

09 янв 2024 04:55:00 Источник Nasdaq GlobeNewswire

Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024

03 янв 2024 05:30:00 Источник Nasdaq GlobeNewswire

Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

08 ноя 2023 04:55:00 Источник Nasdaq GlobeNewswire

Vericel to Present at the Stephens Annual Investment Conference

07 ноя 2023 05:30:00 Источник Nasdaq GlobeNewswire

Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023

25 окт 2023 05:30:00 Источник Nasdaq GlobeNewswire

Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid

28 сен 2023 05:30:00 Источник Nasdaq GlobeNewswire

Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults

20 сен 2023 13:30:00 Источник Nasdaq GlobeNewswire

Vericel to Present at the Morgan Stanley Global Healthcare Conference

06 сен 2023 05:30:00 Источник Nasdaq GlobeNewswire

Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

02 авг 2023 04:55:00 Источник Nasdaq GlobeNewswire

Vericel to Report Second-Quarter 2023 Financial Results on August 2, 2023

20 июл 2023 05:30:00 Источник Nasdaq GlobeNewswire

Vericel Reports First Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

10 май 2023 04:55:00 Источник Nasdaq GlobeNewswire

Vericel to Report First-Quarter 2023 Financial Results on May 10, 2023

26 апр 2023 05:30:00 Источник Nasdaq GlobeNewswire

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Tuesday, March 7, 2023

28 фев 2023 05:30:00 Источник Nasdaq GlobeNewswire

Vericel Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Full-Year 2023 Financial Guidance

23 фев 2023 04:55:00 Источник Nasdaq GlobeNewswire

Vericel to Report Fourth-Quarter 2022 Financial Results on February 23, 2023

09 фев 2023 05:00:01 Источник Nasdaq GlobeNewswire

Vericel Announces Preliminary Fourth-Quarter and Full-Year 2022 Financial Results and Accelerated Launch Timeline for MACI Arthroscopic Program

10 янв 2023 04:55:00 Источник Nasdaq GlobeNewswire